PPMD's Blog – December 2016 Archive (4)
Make my parents pay--48 hours left!
We’re so close to our goal to fund CRISPR/Cas9!…
ContinueAdded by PPMD on December 29, 2016 at 9:30am — No Comments
This could help me--and everyone with Duchenne
Your donation will be DOUBLED. Now is the moment to give.…
ContinueAdded by PPMD on December 22, 2016 at 9:12am — No Comments
Understanding the Path to Access – Resources for the Community
We have all had frustrations getting healthcare paid for, whether it is getting access and coverage for appointments, procedures, equipment, and/or medications.
Coverage is especially difficult when new medicines or procedures are recommended. Parents, patients, and medical providers spend hours putting together documents and…
ContinueI Will Match Your Gift
Help us raise $250,000 to fund CRISPR/Cas9.
After a few months of relative quiet, noise has returned to the Killian house in full force! For the holidays, all five kids are back under one roof with a revolving door of friends and endless groceries. Even with all the chaos that entails, this is my favorite time of…
Added by PPMD on December 13, 2016 at 9:38am — No Comments
Latest Blog Posts
- Capricor Announces New Pre-Clinical Study Finds Repeat Doses of CAP-1002 Lead to Enhanced Exercise Capacity in Duchenne Muscular Dystrophy Disease Model
- Solid Biosciences Provides Update On SGT-001 Clinical Development Program For Duchenne
- Pfizer Doses First Patient Using Investigational Mini-Dystrophin Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
- Roche Restarts RG62026 Phase 2/3 Study
- [WEBINAR] What is a Master Protocol?
- Santhera Shares Duchenne Community Update on SIDEROS Trial
- Sarepta Therapeutics Announces Launch of Route 79, The Duchenne Scholarship Program
Most Popular Blog Posts
- April 25: FDA Advisory Committee Meeting for Eteplirsen - Live Webcast Information
- September 28: FDA Advisory Committee Meeting for Ataluren - Live Webcast Information
- Action ALERT: Urge Congress to Vote YES on 21st Century Cures Act
- Summit Receives Fast Track Designation from FDA for Ezutromid in the Treatment of Duchenne
- Ongoing Traumatic Stress
- PTC Therapeutics to Discuss Launch Plans for Emflaza™ (Deflazacort) during Community Call on Monday, May 8th at 3:00 PM EDT
- Sarepta Therapeutics Announces First Patient Dosed in Phase III Clinical Trial of SRP-4045 & SRP-4053
Monthly Archives
2018
2017
- December (11)
- November (8)
- October (7)
- September (10)
- August (2)
- July (1)
- June (7)
- May (5)
- April (8)
- March (9)
- February (6)
- January (7)
2016
- December (5)
- November (4)
- October (11)
- September (7)
- August (5)
- July (7)
- June (5)
- May (3)
- April (10)
- March (7)
- February (5)
- January (9)
2015
- December (16)
- November (5)
- October (7)
- September (4)
- August (5)
- July (10)
- June (6)
- May (4)
- April (2)
- March (4)
- February (5)
- January (3)
2014
- December (5)
- November (3)
- October (5)
- September (3)
- August (2)
- July (9)
- June (6)
- May (7)
- April (40)
- March (17)
- February (2)
- January (3)
2013
- December (19)
- November (52)
- October (1)
- September (4)
- August (3)
- July (1)
- June (4)
- May (4)
- April (7)
- March (8)
- February (5)
- January (3)
2012
- December (3)
- November (2)
- October (4)
- September (2)
- August (1)
- July (1)
- June (1)
- May (2)
- April (1)
- March (4)
- February (8)
- January (1)
2011
2010
© 2022 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
